Safety and Efficacy of Selinexor Sequential Azacytidine in Newly Diagnosed Patients with Myelodysplastic Syndromes EB1 or EB2: A Single-Center, Single-Arm, Phase Ib/II Trial

被引：0
|
作者：
Ma, Liya [1 ]
Yang, Wenli [1 ]
Zhou, Xinping [1 ]
Ye, Li [1 ]
Xu, Gaixiang [1 ]
Hu, Chao [1 ]
Luo, Yingwan [1 ]
Yang, Chunmei [1 ]
Ge, Zheng [2 ]
Tong, Hongyan [3 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China
[2] Southeast Univ, Zhongda Hosp, Nanjing, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-183101
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Neoadjuvant Toripalimab plus chemotherapy in patients with stage IIB-IIIB NSCLC: A single-center, prospective, single-arm, phase 2 trial (Renaissance Study).
    Yan, Shi
    Chen, Jinfeng
    Wang, Jia
    Lv, Chao
    Bi, Jiwang
    Yang, Xin
    Li, Shaolei
    Wang, Yuzhao
    Li, Xiang
    Yang, Yue
    Wu, Nan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [32] Neoadjuvant sintilimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, single-center, phase 2 trial (ESONICT-1)
    Zhang, Zhenyang
    Hong, Zhi-Nuan
    Xie, Shuhan
    Lin, Wenwei
    Lin, Yukang
    Zhu, Jiafu
    Yang, Xiaojie
    Lin, Zhiwei
    Lin, Jiangbo
    Kang, Mingqiang
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (21)
  • [33] Efficacy and safety of toripalimab with fruquintinib in the third-line treatment of refractory advanced metastatic colorectal cancer: results of a single-arm, single-center, prospective, phase II clinical study
    Ma, Shoucheng
    Chen, Rui
    Duan, Ling
    Li, Chunmei
    Yang, Tianning
    Wang, Jiankai
    Zhao, Da
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (02) : 1052 - 1063
  • [34] Efficacy and Safety Analysis of Transarterial Chemoembolization Plus Donafenib With or Without Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Prospective, Single-Arm, Single-Center, Phase II Clinical Study
    Li, Jinpeng
    Li, Yan
    Song, Jinlong
    Zhao, Lujun
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1207 - 1219
  • [35] Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma
    Kilgour, James M.
    Shah, Aatman
    Urman, Nicole M.
    Eichstadt, Shaundra
    Do, Hanh N.
    Bailey, Irene
    Mirza, Amar
    Li, Shufeng
    Oro, Anthony E.
    Aasi, Sumaira Z.
    Sarin, Kavita Y.
    CLINICAL CANCER RESEARCH, 2021, 27 (17) : 4717 - 4725
  • [36] The efficacy and safety of sequential use of anlotinib and 131I for locally advanced or metastatic differentiated thyroid cancer: A single-arm phase II clinical trial
    Song, Hongjun
    Qiu, Xian
    He, Ziyan
    Chen, Libo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] Surufatinib plus sintilimab in patients with advanced gastric/gastroesophageal junction adenocarcinoma (GC/GEJC): A single-arm, open-label, single-center phase II trial.
    Zhang, Dong-Sheng
    Liu, Fu-Rong
    Lu, Yun-Xin
    Bai, Bing
    Zhang, Yang
    Wang, Zhi-Qiang
    Liu, Yu
    Chen, Jian-Wen
    Wang, Feng
    Xu, Rui-Hua
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 358 - 358
  • [38] Safety and efficacy of ripasudil eye drops in preterm infants with retinopathy of prematurity: phase 1/2, open label, single-arm trial
    Arima, Mitsuru
    Inoue, Hirosuke
    Misumi, Akiko
    Tsukamoto, Shoko
    Matsushita, Itsuka
    Araki, Shunsuke
    Ohta, Manami
    Takahashi, Kazumasa
    Imazato, Miyuki
    Goto, Tomoko
    Aoki, Yoshinori
    Tagawa, Koshiro
    Hirose, Masayuki
    Fujita, Yuito
    Yoshida, Noriko
    Nakao, Shintaro
    Kondo, Hiroyuki
    Kusuhara, Koichi
    Kimura, Kazuhiro
    Hasegawa, Shunji
    Ikeda, Yasuhiro
    Kodama, Yuki
    Moritake, Hiroshi
    Ochiai, Masayuki
    Ohga, Shouichi
    Kishimoto, Junji
    Todaka, Koji
    Ieiri, Ichiro
    Sonoda, Koh-Hei
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2024, 68 (05) : 490 - 499
  • [39] Efficacy and Safety of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma with Extranodal Involvement: A Single-Arm, Prospective Phase II Trial
    Yang, Tao
    Li, Jun
    Zhang, Wenjun
    Guo, Bingling
    Hu, Chongling
    Quan, Xi
    Zeng, Chensi
    Ding, Yao
    Huang, Dehong
    Xiao, Chunyan
    Liu, Jun
    Wu, Jing
    Wang, Chaoyu
    Liang, Xiping
    Zhang, Lingqian
    Yang, Zailin
    Liang, Shunsi
    Hu, Renzhi
    Liu, Tingting
    Li, Qiying
    Li, Jieping
    Nan, Yingyu
    Xiang, Ying
    Liu, Yao
    BLOOD, 2022, 140 : 9540 - 9541
  • [40] Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial
    Kadia, Tapan M.
    Reville, Patrick K.
    Borthakur, Gautam
    Yilmaz, Musa
    Kornblau, Steven
    Alvarado, Yesid
    Dinardo, Courtney D.
    Daver, Naval
    Jain, Nitin
    Pemmaraju, Naveen
    Short, Nicholas
    Wang, Sa A.
    Tidwell, Rebecca S. S.
    Islam, Rabiul
    Konopleva, Marina
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kantarjian, Hagop M.
    LANCET HAEMATOLOGY, 2021, 8 (08): : E552 - E561
12345